LXRX Brings Sweet Tidings, PFE's PROSPER Ahead Of Schedule, XBIT Fails To Excite

Today's Daily Dose brings you news about Lexicon Pharma's inTandem3 results; EyeGate's public offering; Pfizer's progress, Cellect's exit from Israeli Exchange and XBiotech's not so exciting XCITE results.

from RTT - Biotech http://ift.tt/2scR00p
via IFTTT